Article Details

Immuno-oncology startup KAHR to work with Philadelphia university on new drugs

Retrieved on: 2021-04-01 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Immuno-oncology startup KAHR to work with Philadelphia university on new drugs. View article details on hiswai:

Excerpt

Receptors are proteins on the surface of cells that bind to ligands and cause responses in the immune system. “Expanding our collaboration with the ...

Article found on: www.timesofisrael.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo